Related Experiment Videos
Sclerosant therapy for delayed cardiac tampo-nade after coronary artery bypass grafting
S Ishikawa1, M Kamiyoshihara, I Doi
1Second Department of Surgery, Gunma University Faculty of Medicine, Maebashi, Japan.
Insights
Delayed cardiac tamponade after coronary artery bypass grafting (CABG) can occur. Sclerosant therapy, like minocycline hydrochloride, is a potential treatment for this serious complication.
Area of Science:
- Cardiology
- Thoracic Surgery
Background:
- Delayed cardiac tamponade is a rare but serious complication following coronary artery bypass grafting (CABG).
- Early diagnosis and management are crucial for patient outcomes.
Observation:
- A 56-year-old male presented with dyspnea 13 months post-CABG.
- Cardiac tamponade was diagnosed, with pericardiocentesis revealing viscous bloody fluid.
Findings:
- The patient recovered following continuous drainage and intra-pericardial administration of minocycline hydrochloride.
- This case highlights minocycline hydrochloride as a potential therapeutic agent.
Implications:
- Sclerosant therapy, including minocycline hydrochloride, should be considered a primary treatment option for delayed cardiac tamponade post-CABG.
- Further research into the efficacy and safety of sclerosant agents in this context is warranted.
Abstract:
A 56-year-old Japanese male with delayed cardiac tamponade which occurred 13 months after coronary artery bypass grafting (CABG) is presented. The patient was admitted to our hospital suffering from dypnea due to cardiac tamponade. Pericardiocentesis yielded a viscous bloody fluid. The patient recovered after continuous drainage followed by an intra-pericardial administration of minocycline hydrochloride. Sclerosant therapy is considered to be a treatment of choice for delayed cardiac tamponade following CABG.